Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

BACKGROUND: Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate the relationship between the levels of serum FGF19 and endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Meng-jie, Su, Jian‑bin, Xu, Tian-li, Wang, Xue‑qin, Zhang, Dong-mei, Wang, Xiao-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760053/
https://www.ncbi.nlm.nih.gov/pubmed/31572498
http://dx.doi.org/10.1186/s13098-019-0475-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760053/
https://www.ncbi.nlm.nih.gov/pubmed/31572498
http://dx.doi.org/10.1186/s13098-019-0475-1

Ejemplares similares